Home > Financial Ratios > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
AAREY DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results

AAREY DRUGS & PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 11.349.24-25.6820.5517.58

What is the latest Core EBITDA Growth ratio of AAREY DRUGS & PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of AAREY DRUGS & PHARMACEUTICALS is 11.34 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar202511.34
Mar20249.24
Mar2023-25.68
Mar202220.55
Mar202117.58

How is Core EBITDA Growth of AAREY DRUGS & PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 11.34
22.73
Mar2024 9.24
Positive
Mar2023 -25.68
Negative
Mar2022 20.55
16.89
Mar2021 17.58 -

Other Financial Ratios of AAREY DRUGS & PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of AAREY DRUGS & PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AAREY DRUGS & PHARMACEUTICALS ₹233.3 Cr 19.7% 26.3% 63.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,937.0 Cr 1.2% -7% 2.5% Stock Analytics
DIVIS LABORATORIES ₹165,359.0 Cr 1.8% 2.7% 17% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,431.0 Cr 0.5% -4.8% 32.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,114.0 Cr 0.3% -4.5% 11.5% Stock Analytics
CIPLA ₹100,028.0 Cr 0.7% -5.8% -13.1% Stock Analytics


AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AAREY DRUGS & PHARMACEUTICALS

19.7%

26.3%

63.9%

SENSEX

2.4%

3.2%

5.8%


You may also like the below Video Courses